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Abstract
Circadian rhythmicity in mammals is
controlled by the action of a light-
entrainable pacemaker located in the
basal hypothalamus, in association with
two cell clusters known as the supra-
chiasmatic nuclei (SCN). In the absence
of temporal environmental cues, this
pacemaker continues to measure time by an
endogenous mechanism (clock), driving
biochemical, physiological and behavioral
rhythms that reflect the natural period
of the pacemaker oscillation. This endo-
genous period usually differs slightly
from 24 hours (i.e., circadian). When
mammals are maintained under a 24 hour
light-dark (LD) cycle, the pacemaker
becomes entrained such that the period of
the pacemaker oscillation matches that of
the LD cycle. Potentially entraining
photic information is conveyed to the SCN
via a direct retinal projection, the
retinohypothalamic tract (RHT). RHT
neurotransmission is thought to be
mediated by the release of excitatory
amino acids (EAA) in the SCN. In support
of this hypothesis, recent experiments
using nocturnal rodents have shown that
EAA antagonists block the effects of
light on pacemaker-driven behavioral
rhythms, and attenuate light-induced gene
expression in SCN cells. An under-
standing of the neurochemical basis of
the photic entrainment process would
facilitate the development of pharmaco-
logical strategies for maintaining syn-
chrony among shift workers in environ-
ments which provide unreliable or con-
flicting temporal photic cues, such as
the proposed space station.
Photic Entrainment of the Circadian
Pacemaker
Considerable evidence suggests that a
major light-entrainable circadian pace-
maker is located in the ventral hypotha-
lamus in association with the suprachias-
matic nuclei (SCN; Rusak and Zucker,
1979; Meijer and Rietveld, 1989). Bi-
lateral destruction or surgical isolation
of the SCN results in the permanent dis-
ruption of circadian rhythms in mammals
(Inouye et al., 1979; Rusak and Zucker,
1979). Furthermore, transplantation of
the SCN from a fetal donor into the hypo-
thalamus of an SCN-lesioned host restores
rhythmcity (Sawaki et al., 1986; Lehman
et al, 1987; Decousey and Buggy, 1989),
and the period of the restored rhythm
matches that of the donor (Ralph et al.,
1990). In addition, the isolated SCN
continues to display circadian behavior
in vitro. Circadian rhythms in the
neuronal activity (Green and Gillette,
1982; Gillette and Reppert, 1987), neuro-
peptide release (Earnest and Sladek,
1986), and metabolic activity (Newman and
Hospod, 1986) have been demonstrated to
persist for several days in cultured SCN
explants. These observations strongly
suggest that the biological mechanism
responsible for the generation of physio-
logical circadian oscillations is an
intrinsic component of the mammalian SCN.
Photic entrainment of circadian
rhythms occurs as a consequence of the
phase specific effects of environmental
light on the activity of the circadian
pacemaker. This relationship is defined
by the phase response curve to light
pulses administered to animals maintained
under constant darkness (Daan and
Pittendrigh, 1976; Takahashi et al,
1984). In nocturnal rodents, light
pulses administered during the early
subjective night cause phase delays of
the pacemaker while pulses delivered
during the latter half of the subjective
night cause phase advances (Daan and
Pittendrigh, 1976; Takahashi et al.,
1984). Light pulses given during the
middle of the subjective day do not cause
phase shifts. Light-induced shifts
represent long-term alterations in pace-
maker function.
Photic information is conveyed to the
SCN through at least two visual pathways.
The retinohypothalamic tract (RHT) is a
direct, bilateral monosynaptic projection
from retinal ganglion cells to neurons in
the SCN and the surrounding hypothalamus
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(Moore and Lenn, 1971; Johnson et al.,
1988a). In addition, a second, indirect
visual projection, the geniculohypotha-
lamic tract (GHT) has been described.
This pathway projects from the retina to
relay neurons in the intergeniculate
leaflet (IGL) of the thalamus, which, in
turn, send their axons to neurons in the
SCN (Swanson et al., 1974; Card and
Moore, 1982; Pickard, 1982). Lesion
studies have shown that the RHT is both
necessary and sufficient to support
photic entrainment of circadian rhythms
in experimental rodents (Johnson et al.,
1988b).
The Neuropharmacology of Photic
Entrainment
In addition to light, a number of
synthetic and natural neuroactive sub-
stances have been tested for their
ability to reset the circadian pacemaker.
Benzodiazepines (Turek and Losee-Olson,
1986), melatonin (Cassone et al., 1986),
theophylline (Ehret et al., 1975), and
various neuropeptides (Albers et. al.,
1984; Albers et al., 1991) have all been
shown to alter the phase of circadian
oscillations. However, only a few neuro-
transmitter-specific agents have been
systematically investigated for their
effects on light-induced phase
alterations.
Gamma-amino butyric acid. A large pro-
portion of the neurons in the SCN contain
glutamic acid decarboxylase (van den Pol
and Tsujimoto, 1985), the enzyme respon-
sible for the synthesis of the inhibitory
amino acid neurotransmitter, gamma-amino
butyric acid (GABA). Although it is clear
that GABA does not play a direct role in
RHT neurotransmission, the abundance of
GABA-ergic neurons in the SCN raise the
possibility that this neurotransmitter
may participate in the processing of
photic information in the SCN. In fact,
neurophysiological evidence suggests that
GABA modulates retinal input to the SCN
(Shibata et al., 1986), perhaps by acting
presynaptically to regulate neurotrans-
mitter release from RHT terminals (Ralph
and Menaker, 1989). For this reason,
Ralph and coworkers (1985; 1986; 1989)
have investigated the effects of specific
GABA agonists and antagonists on light-
induced phase alterations of the free
running activity rhythm in rodents.
These investigators reported that (a)
GABA A antagonists attenuate light-
induced phase delays (Ralph and Menaker,
1985; 1989), (b) benzodiazepines
attenuate light-induced phase advances
(Ralph and Menaker, 1986; 1989), and (c)
GABA B agonists block both light-induced
phase advances and delays (Ralph and
Menaker, 1989). These results strongly
support a role for the SCN GABA-ergic
system in modulation of photic input to
the circadian pacemaker.
Acetylcholine. Initial investigations
into the identity of the RHT neuro-
transmitter focused on acetylcholine
(ACh). Cholinergic agonists have been
reported to mimic (Zatz and Herkenham,
1981; Earnest and Turek, 1983), and anta-
gonists to block (Zatz and and
Brownstein, 1981; Keefe et al., 1987),
the effects of light on the circadian
system. Furthermore, Earnest and others
(1985) reported that the phase response
curve for intraventricular injections of
the cholinergic agonist, carbachol, are
similar to the phase response curve for
light pulses. This similarity was
offered as evidence that ACh might be the
RHT neurotransmitter. However, neither
retinal ganglion cells nor the optic
nerves contain measurable quantities of
choline acetyltransferase (Hebb and
Silver, 1956), the synthetic enzyme for
ACh, and bilateral lesions of the optic
nerves do not alter the levels of
cholinergic markers in the rat SCN (Rea,
unpublished observations). On the other
hand, the SCN do receive a cholinergic
projection, possibly from the basal fore-
brain (Ichikawa and Hirata, 1986). One
interesting possibility is that ACh from
another source may modulate RHT neuro-
transmission by acting presynaptically
(Rusak and Bina, 1990).
Excitatory Amino Acids. Excitatory amino
acids (EAA) remain the best candidates
for the RHT neurotransmitter. EAA anta-
gonists block fast EPSPs (Kim et al.,
1989) and field potential responses
(Cahill and Menaker, 1987) of SCN neurons
to optic nerve stimulation in the hypo-
thalamic slice preparation. Furthermore,
using the same preparation, Liou et al.
(1986) have reported that optic nerve
stimulation causes the release of radio-
activity from SCN slices preloaded with
radiolabeled EAAs. Recently, Colwell and
colleagues (1990) reported that intra-
peritoneal injections of the non-compe-
titive EAA antagonist MK-801 attenuated
light-induced phase shifts of the free-
running activity rhythm in the mouse. In
order to determine whether EAA anta-
gonists inhibit light-induced phase
shifts by acting on the SCN, we deter-
mined the effect of direct injections of
EAA antagonists into the SCN on light-
induced phases advances of the free-
running activity rhythm in hamsters.
Microinjection of EAA Antagonists into
the SCN Attenuate Light-Induced Phase
Advances
Syrian hamsters were implanted with 26
gauge guide cannulae stereotaxically
aimed at the SCN. The cannulae were
fixed in place with dental cement and the
animals were allowed to recover for 7 -
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i0 days under LD 14:10. After the
recovery period, the hamsters were
transferred to individual cages equipped
with computer-monitored running wheels
and maintained under constant darkness
(DD). Only animals with robust free
running activity rhythms and stable
periods were used in the study. Hamsters
remained in DD for 7 - i0 days before
treatment. At mid subjective night
(CT18.5), hamsters received an injection
of 300 nl of artificial CSF (aCSF)
containing either 1 mM CNQX (a competi-
tive, non-NMDA type EAA antagonist), 1 mM
MK-801 (a non-competitive, NMDA type
antagonist) or no drug (vehicle control)
directly into the suprachiasmatic hypo-
thalamus using a 33 gauge infusion can-
nula. Five minutes after injection, each
animal was exposed to light (30 lux) for
i0 minutes. After light exposure, the
hamsters were returned to their cages and
maintained under DD for an additional i0
days. The effect of treatment on the
phase of the free-running activity rhythm
was determined as described previously
(Daan and Pittendrigh, 1976) using the
onset of wheel running activity as a
phase reference point. Injection sites
were verified histologically and only
data collected from animals with injec-
tion sites within 0.5 mm of the SCN were
included in the analysis.
In the absence of drug injection, light
treatment at this time results in a phase
advance of the free running activity
rhythm of approximately 81 + 8 minutes.
Both drugs attenuated lightUinduced phase
advances by more than 85%. This result
suggests that EAA antagonists inhibit
light-induced phase shifts of the crica-
dian pacemaker by acting directly on the
SCN, possibly at the RHT synapse, and
support a role for EAA as the RHT neuro-
transmitter.
Light-induced Gene Expression
Light-induced resetting of the circa-
dian pacemaker represents a permanent
alteration in pacemaker function. The
c-fos protooncogene has been implicated
in the process of stimulus-transcription
coupling in the CNS (Curran and Morgan,
1987; Sagar et al., 1988) and appears to
mediate long-term adaptive changes in
neuronal function (Berridge, 1986; Goelet
et al., 1986). Recent work in our own
laboratory (Rea, 1989; 1992; Rea and
Michel, 1990) and elsewhere (Kornhauser,
et al., 1990; Rusak et al., 1990; Aronin
et al., 1990) has demonstrated that light
exposure during the subjective night
induces the expression of certain
immediate-early genes, including c-fos,
among a population of SCN cells.
Furthermore, light-induced c-fos expres-
sion only occurs when the light is
administered at a circadian time at which
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Actograms showing the effects of micro-
injections of vehicle (top), 1 mM CNQX
(middle), or 1 mM MK-801 (bottom) on the
light-induced phase advance of the free-
running activity rhythm. In all cases, a
brief light pulse (30 lux for 15 minutes)
was given at CT18.5 (inverted triangle).
a phaseshift of the pacemakeresults(Kornhauseret al., 1990; Rea,and
Michel, 1990; Rea, 1992). Thesefindings
suggest that c-fos expression mayrepre-
sent a transcriptional event in the res-
ponsecascadeleading to light-induced
phasealterations of the pacemaker. If
this is the case, then ould expect
that light-induced phaseshifts and c-fos
expression would share similar
pharmacology.
This hypothesis was tested using our
cannulated hamster model. Hamsters were
housed in LD 14:10 for at least 7 days
after surgery. At lights-out on the day
before the experiment the animals were
transferred to DD. Thiry hours after
transfer (i.e., mid subjective
night) the animals received microinjec-
tions of either aCSF or a solution of EAA
antagonist in aCSF (300 nl at 1 mM)
directly into the SCN. Five minutes
later, each animal was exposed to 30 lux
of white light for I0 minutes and
returned to their cages under DD. Two
hours after the onset of the light pulse,
animals were deeply anesthetized, per-
fused transcardially with 0.4% para-
formaldehyde, and the brains were
processed for c-fos immunocytochemistry
as described previously (Rea, 1989).
Light stimulation induces c-fos
expression among a population of approxi-
mately 1055 + ii0 cells in the SCN. Both
CNQX and MK-801 reduced the number of SCN
cells that expressed c-fos in response to
photic stimulation by about 45%. This
result strenthens our proposal that c-fos
expression represents an early transcrip-
tional event mediating the effects of
light on the SCN circadian pacemaker.
Significance of this Work to Aerospace
Operations
The global mission of the U. S. Air
Force demands that its personnel remain
prepared at all times to participate in
activities which are vital to the
national security and likely to involve
transmeridian air travel and irregular
work schedules for sustained periods. In
responding to this challenge, Air Force
personnel are uniquely vulnerable to the
performance limitations imposed upon them
by the circadian timing system.
Knowledge gained from an investigation
of the neurobiological basis of circadian
rhythmicity will provide the database
necessary for the development of photic
and/or pharmacological strategies for
alleviating the performance decrements
associated with work schedules and prac-
tices which are incompatable with the
circadian timing system. The elucidation
of the mechanism of photic entrainment is
an important step toward a detailed
understanding of circadian processes.
Pharmacological agents with specific
and predictable effects on the circadian
pacemaker could serve as useful tools for
the control of circadian rhythmicity.
For example, it may be possible to
develop a specific antagonist against the
RHT neurotransmitter. Such an agent
could be used to selectively "blind" the
circadian clock to the entraining
influence of environmental light. This
would alleviate the potential conflict
between a shift worker's work-rest cycle
and the environmental LD cycle.
Similarly, pharmacological aids could be
developed which would permit the rapid
resetting of the circadian clock, ac-
celerate rates of reentrainment of overt
rhythms after rapid transmeridian travel,
and maintain synchrony among shift
workers in environments which provide
unreliable or conflicting temporal photic
cues, such as the proposed space station.
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